Literature DB >> 18241695

Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils.

Elzbieta Kolaczkowska1, Bernd Arnold, Ghislain Opdenakker.   

Abstract

Neutrophil infiltration during zymosan peritonitis depends on matrix metalloproteinase-9 (MMP-9) activity as it is impaired both in MMP-9(-/-) and gelatinase inhibitor-treated animals. The producer cells of MMP-9 and their relative contribution are not known. The aim of this study was to identify and compare the cellular sources, timing and intensity of MMP-9 induction by zymosan in the murine peritoneal cavity. We detected MMP-9 mRNA in unstimulated peritoneal leukocytes and its levels increased after zymosan administration. To detect MMP-9 by flow cytometry, we selected and compared two specific monoclonal antibodies. We show that MMP-9 protein was absent in control peritoneal macrophages, whereas already at 30min of peritonitis almost all macrophages were producing the enzyme. Conversely, MMP-9 was constitutively present in unstimulated mast cells. Macrophages turned out to be prevalent MMP-9 producers in the early phase of peritonitis. During later stages macrophages kept the high expression of MMP-9 for at least 6h of inflammation. In contrast, the early phase expression of MMP-9 by neutrophils was limited albeit the highest percentage of MMP-9(+) neutrophils was observed at 2h but absolute numbers of the MMP-9 carrying neutrophils were low at that time. In contrast, during the late phase of peritonitis neutrophils became major producers of MMP-9 as they numerously infiltrated peritoneum. In conclusion, the study reports detection of MMP-9 at the single-cell level during peritonitis, demonstrates unexpectedly fast MMP-9 expression in macrophages and reveals quantitatively phase-specific contribution of mast cells, macrophages and neutrophils.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18241695     DOI: 10.1016/j.imbio.2007.07.005

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  18 in total

1.  Expression profiles of matrix metalloproteinase 9 in teleost fish provide evidence for its active role in initiation and resolution of inflammation.

Authors:  Magdalena Chadzinska; Pawel Baginski; Elzbieta Kolaczkowska; Huub F J Savelkoul; B M Lidy Verburg-van Kemenade
Journal:  Immunology       Date:  2008-06-14       Impact factor: 7.397

2.  Protective effect of a novel antibody against TLR2 on zymosan-induced acute peritonitis in NF-κB transgenic mice.

Authors:  Qingjun Pan; Jun Cai; Yanxia Peng; Haiyan Xiao; Lifang Zhang; Jinying Chen; Huafeng Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  Prenatal exposure to inflammation induced by zymosan results in activation of intrarenal renin-angiotensin system in adult offspring rats.

Authors:  Xue-Qin Hao; Hai-Gang Zhang; Shu-Hui Li; Yi Jia; Ya Liu; Jian-Zhi Zhou; Yan-Ling Wei; Li-Yun Hao; Yuan Tang; Min Su; Xiao-Hui Li
Journal:  Inflammation       Date:  2010-12       Impact factor: 4.092

4.  Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis.

Authors:  Nguyen Dang Hung; Mee Ree Kim; Dai-Eun Sok
Journal:  Inflammation       Date:  2011-06       Impact factor: 4.092

5.  Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory.

Authors:  Long Shuang Huang; Nguyen Dang Hung; Dai-Eun Sok; Mee Ree Kim
Journal:  Lipids       Date:  2010-02-18       Impact factor: 1.880

6.  Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9.

Authors:  Elzbieta Kolaczkowska; Barbara Plytycz; Bernd Arnold; Helene Piccard; Ghislain Opdenakker
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

7.  Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.

Authors:  Anne Sandberg; Jonas H R Hessler; Robert L Skov; Jens Blom; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

8.  Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients.

Authors:  Nicole L Lanza; Allison L McClellan; Hatim Batawi; Elizabeth R Felix; Konstantinos D Sarantopoulos; Roy C Levitt; Anat Galor
Journal:  Ocul Surf       Date:  2016-01-22       Impact factor: 5.033

9.  Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo.

Authors:  Ida K Lund; Morten G Rasch; Signe Ingvarsen; Jesper Pass; Daniel H Madsen; Lars H Engelholm; Niels Behrendt; Gunilla Høyer-Hansen
Journal:  Front Pharmacol       Date:  2012-06-28       Impact factor: 5.810

10.  Up-regulation of cyclooxygenase 2 and matrix metalloproteinases-2 and -9 in cutaneous squamous cell carcinoma: active role of inflammation and tissue remodeling in carcinogenesis.

Authors:  Jeong-Hoon Lee; Mei Shan Piao; Jee-Young Choi; Sook Jung Yun; Jee-Bum Lee; Seung-Chul Lee
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.